Back

Hemadsorption treatment for antithrombotic drug removal in emergency cardiac surgery - cost-benefit analysis comparing patient outcomes

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pathophysiology of acute coronary syndromes Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Kambiz Hassan

Asklepios St. Georg Clinic, Hamburg (Germany)

6 More presentations in this session

Presentation thumbnail
Exercise induced coronary inflammation in masters athletes
Doctor E. Papatheodorou (Athens, GR)
Abstract Slides
Presentation thumbnail
Air pollution and coronary vasomotor disorders in patients with myocardial ischemia and non-obstructive coronary arteries.
Doctor G. La Vecchia (Rome, IT)
Abstract Slides
Presentation thumbnail
Autophagy biomarkers in patients with acute myocardial infarction (AMI)
Assistant Professor M. Kong (Bucheon, KR)
Abstract Slides
Presentation thumbnail
Post-myocardial infarction late diastolic left ventricular blood flow energetics are independently associated with left ventricular remodeling
Doctor A. Demirkiran (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Bleeding outcomes with ticagrelor versus clopidogrel in patients with acute coronary syndrome; a focused analysis from the multicenter CREA ARIAM Andalucia registry
Doctor G. Padilla Rodriguez (Seville, ES)
Abstract Slides

Access the full session

Session thumbnail
Pathophysiology of acute coronary syndromes

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources